Shanghai Sanyou Medical Co Ltd is a China-based company primarily engaged in the research and development, manufacture and sales of medical orthopedics implants and ultrasonic power equipment and consumables. The Companyâ€™s main products include spinal implant consumables, trauma implant consumables, ultrasonic bone dynamic systems, vertebroplasty consumables and other products. The Company is also engaged in the research and development and production of supporting surgical tools. The Company mainly conducts business in the domestic and overseas markets.

Employees

539

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
16/06/26	12.22 ¥	-1.13%	3,144,422
15/06/26	12.36 ¥	-0.72%	2,729,208
12/06/26	12.45 ¥	+2.47%	2,991,993
11/06/26	12.15 ¥	-2.09%	2,290,071
10/06/26	12.41 ¥	-1.80%	3,803,565

End-of-day quote Shanghai S.E.

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

12.22

Average target price

Consensus

EPS Estimates

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

End-of-day quote Shanghai S.E. Other stock markets 16/06/2026			5-day change	1st Jan Change
12.22 ^CNY	-1.13%		-3.30%	-25.41%

04-27	Shanghai Sanyou Medical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-26	Shanghai Sanyou Medical Co., Ltd announces Annual dividend, payable on June 11, 2026	CI

Market Cap	4.48B 663M 571M 526M 494M 928M 62.69B 937M 6.22B 2.42B 30.7B 2.49B 2.44B 106B	P/E Ratio 2026 *	44.1x	P/E Ratio 2027 *	31.3x
Enterprise Value	4.48B 663M 571M 526M 494M 928M 62.69B 937M 6.22B 2.42B 30.7B 2.49B 2.44B 106B	EV / Sales 2026 *	6.58x	EV / Sales 2027 *	5.32x
Free-Float	58.32%	Yield 2026 *	-	Yield 2027 *	-

04-27	Shanghai Sanyou Medical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-26	Shanghai Sanyou Medical Co., Ltd announces Annual dividend, payable on June 11, 2026	CI
03-16	Zhuiyuan Medical Technology Co., Ltd. announced that it has received CNY 25 million in funding from Shanghai Sanyou Medical Co., Ltd, Shanghai Kinetic Medical Co., Ltd	CI
03-05	Shanghai Sanyou Medical's Implanet Secures FDA Clearance for 3D-Printed Spinal System	MT
02-26	Shanghai Sanyou Medical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-12	Sanyou Medical to Acquire Stake in Zhuiyuan Medical for 20 Million Yuan	MT
02-11	Zhuiyuan Medical Technology Co., Ltd. announced that it expects to receive CNY 25 million in funding from Shanghai Sanyou Medical Co., Ltd, Shanghai Kinetic Medical Co., Ltd	CI
27/10/25	Shanghai Sanyou Medical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
26/09/25	Caitong Fund Management Co., Ltd., GF Securities Co., Ltd., Guotai Asset Management Company Limited, Taikang Asset Management Co., Ltd., Shanghai Hongshang Asset Management Center (Limited Partnership) and Guotai Haitong Securities Co., Ltd. acquired 2% stake in Shanghai Sanyou Medical Co., Ltd from QM5 Limited.	CI
23/09/25	Sanyou Medical's Spinal Surgery Robot Passes Drug Regulator's Special Review; Shares Down 4%	MT
22/09/25	Shanghai Sanyou Medical's shareholder plans to sell 2% stake	RE
25/08/25	Shanghai Sanyou Medical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2025	CI
13/08/25	Shanghai Sanyou Medical's shareholder to unload stake	RE

17/11/23	Implanet: l'augmentation de capital approuvée par les actionnaires
28/09/23	Implanet en hausse : projet de lancement d’une augmentation de capital

Shanghai Sanyou Medical Co., Ltd Share Price

Stocks

688085

CNE1000040J7

Medical Equipment, Supplies & Distribution

Valuation: Shanghai Sanyou Medical Co., Ltd

Chart: Shanghai Sanyou Medical Co., Ltd

Latest news : Shanghai Sanyou Medical Co., Ltd

News in other languages: Shanghai Sanyou Medical Co., Ltd

Quotes and Performance

Course Extremes

Managers and Directors: Shanghai Sanyou Medical Co., Ltd

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Quotes

Income Statement and Estimates

Analysts' Consensus

Annual profits - Rate of surprise

1 day	-1.13%
1 week	-3.30%
Current month	-12.20%
1 month	-25.61%
3 months	-35.03%
6 months	-24.27%
Current year	-25.41%

1 week	12.01	12.59
1 month	12.01	16.89
Current year	12.01	21.68
1 year	12.01	23.75
3 years	9.07	23.75
5 years	9.07	28.78
10 years	9.07	56.29

Manager	Title	Age	Since
David Fan SEC	Corporate Secretary	57	28/01/2018
Ming Yan Liu CTO	Chief Tech/Sci/R&D Officer	69	30/04/2014
Nong Xu CEO	Chief Executive Officer	62	30/04/2014

Director	Title	Age	Since
Xu Bo Hu BRD	Director/Board Member	51	30/04/2014
Nong Xu BRD	Director/Board Member	62	30/04/2014
Ming Yan Liu CHM	Chairman	69	30/04/2014

Date	Insider	Type	Main position	Quantity	% Market Cap.
06-09	David Fan	Buy	Founder	1,633,511	0.5206%
06-09	Nong Xu	Buy	Founder	3,929,798	1.2524%
06-09	Yu Li Ma	Buy		43,560	0.0139%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SHANGHAI SANYOU MEDICAL CO., LTD	-1.13%	-3.30%	-15.01%	-38.90%	663M
STRYKER CORPORATION	+0.86%	-1.09%	-17.64%	+5.51%	119B
SMITH & NEPHEW PLC	+0.11%	-2.54%	+4.97%	-9.01%	12.88B
GLAUKOS CORPORATION	-2.01%	+0.94%	+27.35%	+88.32%	7.49B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-1.56%	-0.70%	-47.28%	-72.05%	4.11B
DOUBLE MEDICAL TECHNOLOGY INC.	-1.32%	+1.95%	+14.07%	+33.25%	2.53B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-2.22%	+8.78%	-17.67%	-18.25%	1.75B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-1.85%	-6.60%	+0.64%	-19.24%	1.6B
L&C BIO CO.,LTD	+2.62%	+0.90%	+161.10%	+135.19%	1.4B
Average	-0.72%	+0.38%	+12.28%	+11.65%	16.83B
Weighted average by Cap.	+0.50%	-0.93%	-11.92%	+7.20%

	2026 *	2027 *
Net sales	682M 101M 86.88M 80M 75.12M 141M 9.53B 143M 945M 368M 4.67B 378M 370M 16.18B	843M 125M 107M 98.96M 92.92M 174M 11.79B 176M 1.17B 456M 5.77B 468M 458M 20.01B
Net income	101M 14.94M 12.88M 11.86M 11.13M 20.9M 1.41B 21.12M 140M 54.58M 692M 56.07M 54.88M 2.4B	144M 21.38M 18.42M 16.96M 15.93M 29.9M 2.02B 30.22M 200M 78.09M 990M 80.22M 78.52M 3.43B
Net Debt	-	-